Resultados da pesquisa - Sotiriou, C

A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all? Por Haibe-Kains, B., Desmedt, C., Sotiriou, C., Bontempi, G.

Obter o texto integral Obter o texto integral Obter o texto integral

Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis Por Bareche, Y, Venet, D, Ignatiadis, M, Aftimos, P, Piccart, M, Rothe, F, Sotiriou, C

Obter o texto integral Obter o texto integral Obter o texto integral

Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene Por Wykoff, C C, Sotiriou, C, Cockman, M E, Ratcliffe, P J, Maxwell, P, Liu, E, Harris, A L

Obter o texto integral Obter o texto integral Obter o texto integral

The current use and attitudes towards tumor genome sequencing in breast cancer Por Gingras, I., Sonnenblick, A., de Azambuja, E., Paesmans, M., Delaloge, S., Aftimos, Philippe, Piccart, M. J., Sotiriou, C., Ignatiadis, M., Azim, H. A.

Obter o texto integral Obter o texto integral Obter o texto integral

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients Por de Azambuja, E, Cardoso, F, de Castro, G, Colozza, M, Mano, M S, Durbecq, V, Sotiriou, C, Larsimont, D, Piccart-Gebhart, M J, Paesmans, M

Obter o texto integral Obter o texto integral Obter o texto integral

Gene expression profiling in breast cancer challenges the existence of intermediate histological grade Por Sotiriou, C, Wirapati, P, Loi, S, Harris, A, Bergh, J, Smeds, J, Praz, V, Farmer, P, Haibe-Kains, B, Lallemand, F, Buyse, M, Piccart, M, Delorenzi, M

Obter o texto integral Obter o texto integral

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective tria... Por Loibl, S., Majewski, I., Guarneri, V., Nekljudova, V., Holmes, E., Bria, E., Denkert, C., Schem, C., Sotiriou, C., Loi, S., Untch, M., Conte, P., Bernards, R., Piccart, M., von Minckwitz, G., Baselga, J.

Obter o texto integral Obter o texto integral Obter o texto integral

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective tria... Por Loibl, S, Majewski, I, Guarneri, V, Nekljudova, V, Holmes, E, Bria, E, Denkert, C, Schem, C, Sotiriou, C, Loi, S, Untch, M, Conte, P, Bernards, R, Piccart, M, von Minckwitz, G, Baselga, J

Obter o texto integral Obter o texto integral Obter o texto integral

Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial Por Buisseret, L, Pommey, S, Allard, B, Garaud, S, Bergeron, M, Cousineau, I, Ameye, L, Bareche, Y, Paesmans, M, Crown, J P A, Di Leo, A, Loi, S, Piccart-Gebhart, M, Willard-Gallo, K, Sotiriou, C, Stagg, J

Obter o texto integral Obter o texto integral Obter o texto integral

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial Por Shi, W., Jiang, T., Nuciforo, P., Hatzis, C., Holmes, E., Harbeck, N., Sotiriou, C., Peña, L., Loi, S., Rosa, D. D., Chia, S., Wardley, A., Ueno, T., Rossari, J., Eidtmann, H., Armour, A., Piccart-Gebhart, M., Rimm, D. L., Baselga, J., Pusztai, L.

Obter o texto integral Obter o texto integral Obter o texto integral

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial Por Shi, W, Jiang, T, Nuciforo, P, Hatzis, C, Holmes, E, Harbeck, N, Sotiriou, C, Peña, L, Loi, S, Rosa, D D, Chia, S, Wardley, A, Ueno, T, Rossari, J, Eidtmann, H, Armour, A, Piccart-Gebhart, M, Rimm, D L, Baselga, J, Pusztai, L

Obter o texto integral Obter o texto integral Obter o texto integral

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial Por Shi, W, Jiang, T, Nuciforo, P, Hatzis, C, Holmes, E, Harbeck, N, Sotiriou, C, Peña, L, Loi, S, Rosa, D D, Chia, S, Wardley, A, Ueno, T, Rossari, J, Eidtmann, H, Armour, A, Piccart-Gebhart, M, Rimm, D L, Baselga, J, Pusztai, L

Obter o texto integral Obter o texto integral Obter o texto integral

Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions Por Pradeep, C-R, Zeisel, A, Köstler, WJ, Lauriola, M, Jacob-Hirsch, J, Haibe-Kains, B, Amariglio, N, Ben-Chetrit, N, Emde, A, Solomonov, I, Neufeld, G, Piccart, M, Sagi, I, Sotiriou, C, Rechavi, G, Domany, E, Desmedt, C, Yarden, Y

Obter o texto integral Obter o texto integral Obter o texto integral

The AURORA initiative for metastatic breast cancer Por Zardavas, D, Maetens, M, Irrthum, A, Goulioti, T, Engelen, K, Fumagalli, D, Salgado, R, Aftimos, P, Saini, K S, Sotiriou, C, Campbell, P, Dinh, P, von Minckwitz, G, Gelber, R D, Dowsett, M, Di Leo, A, Cameron, D, Baselga, J, Gnant, M, Goldhirsch, A, Norton, L, Piccart, M

Obter o texto integral Obter o texto integral Obter o texto integral

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 Por Salgado, R., Denkert, C., Demaria, S., Sirtaine, N., Klauschen, F., Pruneri, G., Wienert, S., Van den Eynden, G., Baehner, F. L., Penault-Llorca, F., Perez, E. A., Thompson, E. A., Symmans, W. F., Richardson, A. L., Brock, J., Criscitiello, C., Bailey, H., Ignatiadis, M., Floris, G., Sparano, J., Kos, Z., Nielsen, T., Rimm, D. L., Allison, K. H., Reis-Filho, J. S., Loibl, S., Sotiriou, C., Viale, G., Badve, S., Adams, S., Willard-Gallo, K., Loi, S.

Obter o texto integral Obter o texto integral Obter o texto integral